Flagship-founded Tessera fuels up with $300M 'to go on a really big adventure' in gene editing - Endpoints News

A few years ago, the gene editing approach at Tessera was just a “twinkle in our eye,” CEO and co-founder Geoff von Maltzahn said. Nucleases — the crucial machinery underlying the gene editing field — do a pretty good job of cutting DNA, allowing scientists t…

A few years ago, the gene edit­ing ap­proach at Tessera was just a “twin­kle in our eye,” CEO and co-founder Ge­off von Maltzahn said. Nu­cle­as­es — the cru­cial ma­chin­ery un­der­ly­ing the gene … [+3737 chars]

full article...